Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 36413710

Overall Survival With Daratumumab, Bortezomib, and Dexamethasone in Previously Treated Multiple Myeloma (CASTOR): A Randomized, Open-Label, Phase III Trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2023 Mar 10
First author
Sonneveld P

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2023 May 10;41(14):2668. doi: 10.1200/JCO.22.02850.
    note
    Source null
    related pmid
    36940403
    relationship
    Comment in
  2. citation
    J Clin Oncol. 2023 May 10;41(14):2667-2668. doi: 10.1200/JCO.22.02665.
    note
    Source null
    related pmid
    36940404
    relationship
    Comment in

Authors and identifiers

  1. name
    Sonneveld P
    type
    Author
  2. name
    Chanan-Khan A
    type
    Author
  3. name
    Weisel K
    type
    Author
  4. name
    Nooka AK
    type
    Author
  5. name
    Masszi T
    type
    Author
  6. name
    Beksac M
    type
    Author
  7. name
    Spicka I
    type
    Author
  8. name
    Hungria V
    type
    Author
  9. name
    Munder M
    type
    Author
  10. name
    Mateos MV
    type
    Author
  11. name
    Mark TM
    type
    Author
  12. name
    Levin MD
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Sonneveld P
    type
    Author
  2. name
    Chanan-Khan A
    type
    Author
  3. name
    Weisel K
    type
    Author
  4. name
    Nooka AK
    type
    Author
  5. name
    Masszi T
    type
    Author
  6. name
    Beksac M
    type
    Author
  7. name
    Spicka I
    type
    Author
  8. name
    Hungria V
    type
    Author
  9. name
    Munder M
    type
    Author
  10. name
    Mateos MV
    type
    Author
  11. name
    Mark TM
    type
    Author
  12. name
    Levin MD
    type
    Author
bibliography ids
  1. nci-bib-5079a9f6fc19f9017574f3e1
book metadata
content sha256
c5ab6305ff75e822b15a841605b47bbdf9386094e4b1771c5a0ba16042f92e2d
document type
citation
dois
  1. 10.1200/JCO.21.02734
electronic publication date
display
2022 Nov 22
precision
day
year
2022
evidence scope
bibliographic_metadata_only
id
pubmed:36413710
immutable id
pubmed:36413710@c5ab6305ff75e822b15a841605b47bbdf9386094e4b1771c5a0ba16042f92e2d
journal
abbreviation
J Clin Oncol
issn electronic
1527-7755
issn print
0732-183X
issue
8
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
1600-1609
volume
41
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2023 May 10;41(14):2668. doi: 10.1200/JCO.22.02850.
    note
    Source null
    related pmid
    36940403
    relationship
    Comment in
  2. citation
    J Clin Oncol. 2023 May 10;41(14):2667-2668. doi: 10.1200/JCO.22.02665.
    note
    Source null
    related pmid
    36940404
    relationship
    Comment in
outcomes validated
false
pmid
36413710
provenance
batch id
d370e99271168e8a8a13
provider
NCBI PubMed ESummary
record sha256
7aa89ecaed74891af217d58a9280a487ae0d24e88898b642511964c8cde1f9d5
response sha256
f65ace3ceb1efa86f3fbab8e01ce265243e7c6b7f13c5f71c357c1f219ad79c4
retrieved at
2026-09-09T23:48:13.005737+00:00
publication date
display
2023 Mar 10
precision
day
year
2023
publication types
  1. Randomized Controlled Trial
  2. Multicenter Study
  3. Clinical Trial, Phase III
  4. Journal Article
  5. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/36413710/
title
Overall Survival With Daratumumab, Bortezomib, and Dexamethasone in Previously Treated Multiple Myeloma (CASTOR): A Randomized, Open-Label, Phase III Trial.

Preserved source evidence · Not medical advice